• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Monitoring of high-dose fosfomycin guided by NT-proBNP.

作者信息

Candel Francisco Javier, Matesanz Mayra, Martín-Sánchez Francisco Javier, González Del Castillo Juan Maria

机构信息

Department of Clinical Microbiology and Infectious Diseases, Spain.

Department of Internal Medicine, Spain.

出版信息

Int J Cardiol. 2016 Apr 15;209:131-2. doi: 10.1016/j.ijcard.2016.02.037. Epub 2016 Feb 3.

DOI:10.1016/j.ijcard.2016.02.037
PMID:26889596
Abstract
摘要

相似文献

1
Monitoring of high-dose fosfomycin guided by NT-proBNP.N末端B型利钠肽原（NT-proBNP）引导下的高剂量磷霉素监测
Int J Cardiol. 2016 Apr 15;209:131-2. doi: 10.1016/j.ijcard.2016.02.037. Epub 2016 Feb 3.
2
Cost-effectiveness of N-terminal pro-B-type natriuretic-guided therapy in elderly heart failure patients: results from TIME-CHF (Trial of Intensified versus Standard Medical Therapy in Elderly Patients with Congestive Heart Failure).N-末端脑利钠肽前体指导治疗老年心力衰竭患者的成本效益：TIME-CHF 研究（充血性心力衰竭老年患者强化与标准药物治疗比较试验）的结果。
JACC Heart Fail. 2013 Feb;1(1):64-71. doi: 10.1016/j.jchf.2012.08.002. Epub 2013 Feb 4.
3
The relationship between N-terminal pro-brain natriuretic peptide and risk for hospitalization and mortality is curvilinear in patients with chronic heart failure.在慢性心力衰竭患者中，N 末端前脑钠肽与住院风险和死亡率之间的关系呈曲线相关。
Am Heart J. 2007 Jul;154(1):123-9. doi: 10.1016/j.ahj.2007.04.002.
4
Cautious application of pleural N-terminal pro-B-type natriuretic peptide in diagnosis of congestive heart failure pleural effusions among critically ill patients.重症患者中谨慎应用胸膜N末端B型利钠肽原诊断充血性心力衰竭胸腔积液
PLoS One. 2014 Dec 12;9(12):e115301. doi: 10.1371/journal.pone.0115301. eCollection 2014.
5
The clearance of BNP modeled using the NT-proBNP-BNP relationship.利用N端脑钠肽前体（NT-proBNP）与脑钠肽（BNP）的关系对BNP清除率进行建模。
Biosystems. 2007 Mar;88(1-2):147-55. doi: 10.1016/j.biosystems.2006.05.004. Epub 2006 May 26.
6
Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.静脉注射铁剂可降低合并慢性心力衰竭和肾功能不全的贫血患者的N末端脑钠肽前体水平。
J Am Coll Cardiol. 2007 Oct 23;50(17):1657-65. doi: 10.1016/j.jacc.2007.07.029.
7
Is high-dose intravenous fosfomycin safe for the treatment of patients prone to heart failure?大剂量静脉注射磷霉素治疗易发生心力衰竭的患者是否安全？
Enferm Infecc Microbiol Clin. 2015 Apr;33(4):294. doi: 10.1016/j.eimc.2014.07.005. Epub 2014 Oct 23.
8
Clinical and echocardiographic characteristics of elderly hospitalized patients with high levels of NT-proBNP without clinical diagnosis of heart failure.NT-proBNP水平升高但无心力衰竭临床诊断的老年住院患者的临床和超声心动图特征
Aging Clin Exp Res. 2014 Dec;26(6):607-13. doi: 10.1007/s40520-014-0226-y. Epub 2014 Apr 30.
9
Changes of natriuretic peptides predict hospital admissions in patients with chronic heart failure: a meta-analysis.利钠肽变化预测慢性心力衰竭患者的住院：一项荟萃分析。
JACC Heart Fail. 2014 Apr;2(2):148-58. doi: 10.1016/j.jchf.2013.11.007.
10
Relationships between cardiac resynchronization therapy and N-terminal pro-brain natriuretic peptide in patients with heart failure and markers of cardiac dyssynchrony: an analysis from the Cardiac Resynchronization in Heart Failure (CARE-HF) study.心力衰竭伴心脏不同步标志物患者心脏再同步治疗与 N 末端脑利钠肽前体的关系：心力衰竭心脏再同步治疗（CARE-HF）研究的分析。
Eur Heart J. 2009 Sep;30(17):2109-16. doi: 10.1093/eurheartj/ehp210. Epub 2009 Jun 2.

引用本文的文献

1
Efficacy and Safety of Fosfomycin Disodium in Patients with Bacterial Infections: A Single-Center, Real-Life Clinical Study.磷霉素钠治疗细菌感染患者的疗效与安全性：一项单中心、真实临床研究
J Clin Med. 2025 Jun 19;14(12):4386. doi: 10.3390/jcm14124386.
2
The Impact of Fosfomycin on Gram Negative Infections: A Comprehensive Review.磷霉素对革兰氏阴性菌感染的影响：一项全面综述。
Indian J Microbiol. 2024 Sep;64(3):846-858. doi: 10.1007/s12088-024-01293-8. Epub 2024 May 7.
3
Clinical Use of Intravenous Fosfomycin in Critical Care Patients in Taiwan.
台湾地区重症患者静脉注射磷霉素的临床应用
Pathogens. 2023 Jun 18;12(6):841. doi: 10.3390/pathogens12060841.
4
Deciphering pharmacokinetics and pharmacodynamics of fosfomycin.解读磷霉素的药代动力学和药效学。
Rev Esp Quimioter. 2019 May;32 Suppl 1(Suppl 1):19-24.
5
New perspectives for reassessing fosfomycin: applicability in current clinical practice.重新评估磷霉素的新视角：在当前临床实践中的适用性
Rev Esp Quimioter. 2019 May;32 Suppl 1(Suppl 1):1-7.